Alkalosis: Clinical Trials

18 trials for Alkalosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed, 5 unknown, 1 recruiting, 1 terminated. 7 Not applicable, 3 Phase 3, 1 Phase 2, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable7Completed 5, Unknown 2
Phase 33Completed 2, Terminated 1
Phase 21Terminated 1
Phase 41Completed 1

Follow Alkalosis: new trials by email Literature Review of Alkalosis trials Research Report on Alkalosis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Re-Adjustment of Sweep Gas Flow to the During the Rewarming Period of the Cardiopulmonary Bypass
Gas Flow Adjustment - Optimal Sweep Gas Flow, Determination of Optimal Sweep Gas Flow for Different Phases of Cardiopulmonary Bypass
RecruitingAcıbadem Atunizade Hospital902023-08-072023-08-28
Effects of Sodium Bicarbonate Supplementation on Intermittent and Intense Task
Sodium bicarbonate, Calcium carbonate - Sodium Bicarbonate, Alkalosis, Metabolic
Not applicableUnknownUniversity of Nove de Julho122019-10-202019-10-17
Determination of the Dissociation Constant (Ka) of Plasma and Whole Blood in Septic Patients
In vitro determination the dissociation constant (Ka) and total amount of non-volatile buffers (Atot) in isolated plasma., In vitro determination the dissociation constant (Ka) and total amount of non-volatile buffers (Atot) in whole blood, Biomolecular analysis of plasma proteins. - Sepsis, Septic Shock
UnknownFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico902019-06-032019-06-04
Evaluation of Respiratory Function in Fibromyalgia
Fibromyalgia, Respiratory Alkalosis and Metabolic Acidosis
CompletedUppsala University902018-06-282022-03-21
The Effect of Bicarbonate Profiling in Dialysis Fluid on Phosphate Removal During Hemodialysis and Blood pH
Group 1: B) Dbic 35 -30 mmol/L C) Dbic 30- 35 mmol/L, Group 2: C) Dbic 30 -35 mmol/L B) Dbic 35- 30 mmol/L - Phosphorus Metabolism Disorders, Acid-Base Balance Disorder
Not applicableCompletedMedical University of Warsaw202018-05-212023-05-23
Cerebrospinal Acid-base in Pregnant and Non-pregnant Fertile Women
Acid - Base characterization - Acid-Base Imbalance, Respiratory Alkalosis
UnknownFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico402018-04-132018-04-17
Non Carbonic Buffer Power of Critical Ill Patients With Sepsis
In vitro determination of non-carbonic buffer power, Classic description of acid-base status - Acid-Base Imbalance, Respiratory Acidosis
CompletedFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico362018-03-072019-04-25
Comparison of Transcutaneous Vs End-tidal CO2 Pressure Measurements in Hyperventilation Syndrome Diagnosis
Simultaneous Transcutaneous and End-tidal CO2 measurements - Hyperventilation Syndrome, Hypocapnia
Not applicableCompletedUniversity Hospital, Rouen142017-12-212020-06-29
Is Venous to Arterial Conversion (v-TAC) of Blood Gas Reliable in Critical Ill Patients in the ICU?
venous to arterial conversion (v-TAC) - Respiratory Insufficiency, Metabolic Disease
UnknownAalborg University502017-10-092017-10-13
Effect of the Diet on Urinary Excretion of Alpha-ketoglutarate
Meat and vegetable diet - Acid Base Disorder
Not applicableCompletedMichel Burnier322013-06-012019-07-31
Chronic Versus Acute Dosing of Sodium Citrate for Swimming 200m
Sodium Citrate Dihydrate - Alkalosis
Phase 3CompletedBrock University102012-09-012014-07-24
Carbon Dioxide (Carbogen) for the Treatment of Febrile Seizures
Carbogen, Placebo - Febrile Seizure
Phase 2 / Phase 3TerminatedCharite University, Berlin, Germany962012-08-012018-01-26
Treatment of Metabolic Alkalosis With Acetazolamide. Effect on the Length of Mechanical Ventilation.
Acetazolamide, Placebo - Pulmonary Disease, Chronic Obstructive, Obesity Hypoventilation Syndrome
Phase 3CompletedHospital Son Llatzer1402011-11-012015-03-17
Respiratory Physiology in Children With Febrile Seizures.
Febrile Illness Acute, Seizures, Febrile
CompletedCharite University, Berlin, Germany1002011-07-012026-01-02
Normalizing CO2 in Chronic Hyperventilation by a Novel Breathing Mask: A Pilot Study
Partial Rebreathing Mask - Hyperventilation, Chronic Idiopathic Hyperventilation
Not applicableCompletedUniversity of Aarhus62011-02-012016-05-19
Acetazolamide Facilitates Ventilator Weaning
acetazolamide, Saline - Ventilator Weaning, Alkalosis, Metabolic
Not applicableUnknownAsan Medical Center1502010-05-012010-05-27
Clinical Evidence of pH Dependent ß2 Adrenergic Transport Mechanisms in the Airway
quiet breathing, Hypocapnic Hyperventilation, Hypercapnic Hyperventilation - Healthy Volunteers
Not applicableCompletedUniversity of Miami102010-01-012016-05-27
Acetazolamide for Respiratory Failure in Combination With Metabolic Alkalosis
Acetazolamide, Placebo - Respiratory Insufficiency, Alkalosis
Phase 4CompletedUniversity of Oslo School of Pharmacy702002-01-012014-01-20

Narrower conditions

Alkalosis, Respiratory (8)  ·  Acidosis (5)  ·  Acid-Base Imbalance (3)  ·  Acidosis, Respiratory (3)  ·  Hyperventilation (2)  ·  Respiratory Aspiration (2)  ·  Respiratory Insufficiency (2)  ·  Seizures, Febrile (2)  ·  Sepsis (2)  ·  Abdomen, Acute (1)  ·  Critical Illness (1)  ·  Fatigue (1)  ·  Fibromyalgia (1)  ·  Hypocapnia (1)

Broader conditions

Nutritional and Metabolic Diseases (18)  ·  Metabolic Diseases (17)  ·  Acid-Base Imbalance (15)  ·  Respiration Disorders (11)  ·  Respiratory Tract Diseases (11)  ·  Pathological Conditions, Signs and Symptoms (9)  ·  Hyperventilation (6)  ·  Signs and Symptoms (6)  ·  Nervous System Diseases (4)  ·  Pathologic Processes (4)  ·  Respiratory Insufficiency (4)  ·  Acidosis (3)  ·  Neurologic Manifestations (3)  ·  Disease Attributes (2)

Interventions

Acetazolamide (3)  ·  Calcium Carbonate (1)  ·  Meat (1)  ·  Oxygen (1)  ·  Sodium Bicarbonate (1)  ·  Sodium Chloride (1)  ·  Sodium Citrate (1)  ·  carbogen (1)

Sponsors

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico (3)  ·  Charite University, Berlin, Germany (2)  ·  Aalborg University (1)  ·  Acıbadem Atunizade Hospital (1)  ·  Asan Medical Center (1)  ·  Brock University (1)  ·  Hospital Son Llatzer (1)  ·  Medical University of Warsaw (1)  ·  Michel Burnier (1)  ·  University Hospital, Rouen (1)  ·  University of Aarhus (1)  ·  University of Miami (1)  ·  University of Nove de Julho (1)  ·  University of Oslo School of Pharmacy (1)  ·  Uppsala University (1)

Countries

Italy (3)  ·  Denmark (2)  ·  Germany (2)  ·  Brazil (1)  ·  Canada (1)  ·  Czechia (1)  ·  France (1)  ·  Norway (1)  ·  Poland (1)  ·  South Korea (1)  ·  Spain (1)  ·  Sweden (1)  ·  Switzerland (1)  ·  Turkey (Türkiye) (1)  ·  United States (1)

Top investigators

Thomas Langer, MD (3)  ·  Antonio Pesenti, MD (2)  ·  Giacomo Grasselli, MD (2)  ·  Antonio M Pesenti, MD (1)  ·  Chae-Man Lim, professor (1)  ·  Edoardo Calderini, MD (1)  ·  Frantisek Duska, MD (1)  ·  Giorgio Giudici, MD (1)  ·  Magnus Peterson, MD PhD (1)  ·  Mariateresa Ambrosini, MD (1)  ·  Markus Schuelke, MD (1)  ·  Matthias Salathe (1)  ·  Michel Burnier, professor (1)

Results publications

PMID 23578004, PMID 24944546, PMID 25889594, PMID 28286047, PMID 36096944, PMID 40706939, PMID 41433250

NIH funding

R01HL060644 (1)